"Optimizing Outcomes in ALS: Best Practices in Screening, Diagnosis, and Treatment" is a modular continuing education series led by Dr. Richard Bedlack, a nationally recognized ALS expert. This self-navigation program focuses on amyotrophic lateral sclerosis (ALS), providing healthcare professionals with valuable insights and evidence-based strategies to enhance outcomes in ALS care. Participants have the flexibility to choose their own track and explore various modules, covering clinical considerations from early recognition to comprehensive care delivery, while emphasizing the importance of a multidisciplinary approach for improved survival, reduced morbidity, and enhanced quality of life. Dr. Bedlack's expertise and the program's interactive format ensure that participants gain the knowledge and skills necessary to optimize screening, diagnosis, and treatment in ALS.
Course Credit:
0.75 ACPE Contact Hours
0.75 AMA PRA Category 1 CreditsTM
0.75 ANCC Contact Hours
0.75 CA-BRN Contact Hours
Dates:
Opens: 2023-05-31
Closes: 2024-05-31
Target Audience:
This activity is intended for neurologists, neuromuscular specialists, primary care physicians, internists, advanced practitioners (nurse practitioners; physician associates), pharmacists and nurses.
This activity is supported by an educational grant from Amylyx Medical and Mitsubishi Tanabe Pharma America, Inc.
Accreditation
The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Annenberg Center for Health Sciences at Eisenhower designates this knowledge-based activity for a maximum of 0.75 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.
Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.75 contact hours.
To receive credit for education contact hours outside of the state of California, please check with your state board of registered nursing for reciprocity.
Additional Content Planners
Eugene Cullen, MD (Peer Reviewer)No significant relationships to disclose.
Heather Jimenez, MSN, FNP-C (Nurse Reviewer)
No significant relationships to disclose.
Sunali Wadehra, MD (Medical Writer)
No significant relationships to disclose.
Annenberg Center for Health Sciences
Staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant financial relationships to disclose.
All of the financial relationships listed for these individuals have been mitigated.
-
.jpg)
Richard Bedlack, MD, PhD
Professor of Neurology
Faculty Network Member of the Duke Institute for Brain Sciences
Associate of the Duke Initiative for Science & Society
Duke University
Durham, North Carolina
Presenting Faculty
Downloads
Learning Objectives
- Recognize key signs and symptoms that may be suggestive of ALS
- Select evidence-based treatment for patients with ALS that may prolong and improve quality of life and functioning
- Design a comprehensive, evidence-based treatment plan for patients with ALS that is based on a model of multidisciplinary, interprofessional, and collaborative care
Faculty Disclosures
Richard Bedlack, MD, PhD
Consultant: Amylyx, Apellis Pharmaceuticals, BioMedical Insights, Inc, Biogen Idec Inc, Black Swan Pharmaceuticals, Clarivate Analytics, Clearview Health Partners, Clene Nanomedicine, Gerson Lehrman Group Inc, Guidepoint Global, Health Advances, Windrose Consulting Group
Data Safety Monitoring Board: AB Science, Biogen Idec Inc, IONIS Pharmaceuticals, NeuroSense, PTC Therapeutics,
Scientific Advisory Board: GenieUS